Sleep Medicine
Volume 5, Issue 1 , Pages 67-75 , January 2004

Studio Morfeo: insomnia in primary care, a survey conducted on the Italian population

  • Mario Giovanni Terzano

      Affiliations

    • Sleep Disorders Center, University of Parma, Via del Quartiere 4, Parma 43100, Italy
    • Corresponding Author InformationCorresponding author. Address: Istituto di Neurologia-Universitá, Via del Quartiere 4, 43100 Parma, Italy. Tel./fax: +39-0521-287913
    • ,
  • Liborio Parrino

      Affiliations

    • Sleep Disorders Center, University of Parma, Via del Quartiere 4, Parma 43100, Italy
    • ,
  • Fabio Cirignotta

      Affiliations

    • Sleep Center, Unit of Neurology, S. Orsola-Malpighi Hospital, Bologna, Italy
    • ,
  • Luigi Ferini-Strambi

      Affiliations

    • Sleep Disorders Center, Università Vita Salute, Scientific Institute H S. Raffaele, Milano, Italy
    • ,
  • Gianluigi Gigli

      Affiliations

    • Sleep Disorders Center, Department of Neurosciences, S. Maria della Misericordia, Udine, Italy
    • ,
  • Giuseppa Rudelli

      Affiliations

    • Medical Department, Sanofi-Synthelabo, Italy
    • ,
  • Sergio Sommacal

      Affiliations

    • Medical Department, Sanofi-Synthelabo, Italy
    • ,
  • on behalf of the Studio Morfeo Committee

      Affiliations

    • See Acknowledgments.

Received 28 February 2003 ,Revised 19 August 2003 ,Accepted 3 September 2003.

References 

  1. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97–111
  2. Lugaresi E, Cirignotta F, Zucconi M, et al.  Good and poor sleepers: an epidemiological survey of the San Marino population. In:  Guilleminault C,  Lugaresi E editor. Sleep/wake disorders: natural history, epidemiology, and long-term evolution. New York: Raven Press; 1983;
  3. Granella F, Spaggiari MC, Parrino L, Terzano MG. Insonnia e uso di ipnoinducenti: studio epidemiologico sulla popolazione italiana. In:  Di Perri R,  Raffaele M,  Silvestri R,  Smirne S editor. Il Sonno in Italia 1994. Milano: Poletto Editore; 1995;p. 2–11
  4. Gallup Organization. Sleep in America 1995. The Gallup Organization, November 1995.
  5. Hajak G. Insomnia in primary care. Sleep. 2000;23(suppl. 3):S54–S63
  6. Léger D. Public health and insomnia: economic impact. Sleep. 2000;23(suppl. 3):S69–S76
  7. Stoller MK. Economic effects of insomnia. Clin Ther. 1994;16:873–896
  8. Hatoum HT, Kong SX, Kania CM, Wong JM, Mendelson WB. Insomnia, health-related quality of life and health-care resource consumption. A study of managed-care organisation enrollees. Pharmacoeconomics. 1998;14:629–637
  9. Dement WC, Pelayo R. Public health and treatment of insomnia. Eur Psychiatry. 1997;12(suppl. 1):31s–39s
  10. Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep. 1999;22(suppl. 2):S386–S393
  11. Léger D, Levy E, Paillard M. The direct costs of insomnia in France. Sleep. 1999;22(suppl. 2):S394–S401
  12. Ware JE, Snow KK, Kosinski M, et al.  SF-36 health survey manual and interpretation guide. Boston, MA: New England Medical Center; 1998; p. 1–12
  13. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th edition (DSM-IV). Washington, DC: American Psychiatric Association; 1994;
  14. International classification of sleep disorders . Diagnostic and coding manual. Diagnostic Classification Steering Committee. Lawrence, KS: Allen Press; 1990;
  15. Apolone G, Mosconi P, Ware JE. Questionario sullo stato di salute SF36. Editore Guerini and Associati; 1997;
  16. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. London: Lawrence Erlbaum; 1977;
  17. Zammit GK, Weiner J, Damato N, et al.  Quality of life in people with insomnia. Sleep. 1999;22(suppl. 2):S379–S385
  18. Bixler EO, Kales A, Soldatos CR, et al.  Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry. 1979;136:1257–1262
  19. Mellinger GD, Baiter MB, Uhlenhuth EH. Insomnia and its treatment: prevalence and correlates. Arch Gen Psychiatry. 1985;42:225–232
  20. Ohayon M. Epidemiological study on insomnia in the general population. Sleep. 1996;19:S7–S15
  21. Blais FC, Morin CM, Boisclair A, et al.  Insomnia. Prevalence and treatment of patients in general practice. Can Fam Physician. 2001;47:759–767
  22. Haldeman R, Good M, Holsboer-Trachsler E. Epidemiological study of sleep disorders in patients in Swiss general practice. Schweiz Rundsch Med Prax. 1996;85:1656–1662
  23. Janson C, Lindberg E, Gislason T, et al.  Insomnia in men—a 10-year prospective population based study. Sleep. 2001;24:425–430
  24. Klink ME, Quan SF, Kaltenborn WT, Lebowitz MD. Risk factors with complaints of insomnia in a general adult population. Influence of previous complaints of insomnia. Arch Intern Med. 1992;152:1634–1637
  25. Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep. 1999;22(suppl. 2):S347–S353
  26. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention?. J Am Med Assoc. 1989;262:1479–1484
  27. Hohagen F, Rink K, Kappler C, et al.  Prevalence and treatment of insomnia in general practice. Eur Arch Psychiatry Clin Neurosci. 1993;242:329–336
  28. Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry. 1997;154:1417–1423
  29. Shochat T, Umphress J, Israel AG, Ancoli-Israel S. Insomnia in primary care. Sleep. 1999;22(suppl. 2):S359–S365

☆ Part of the results were presented in Abstract form at the 2001 APSS congress.

PII: S1389-9457(03)00232-6

doi: 10.1016/j.sleep.2003.09.006

Sleep Medicine
Volume 5, Issue 1 , Pages 67-75 , January 2004

Article Tools

* Image Usage & Resolution